Gagan Brar: Systemic Chemotherapy Shows No Added Role With CRS/HIPEC in Appendiceal Cancers
Gagan Brar/X

Gagan Brar: Systemic Chemotherapy Shows No Added Role With CRS/HIPEC in Appendiceal Cancers

Gagan Brar, Assistant Clinical Professor of the Department of Medical Oncology and Therapeutics Research at City of Hope, shared a post on X, about a recent article she and her colleagues co-authored, adding:

“Just published – The role of systemic chemotherapy to CRS/HIPEC in patients with appendiceal cancers

No role for systemic chemo

Where does chemo fit”

GI26 Abstract#840 also shows no benefit of AC in early stage disease.”

Title: The role of systemic chemotherapy to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with appendiceal cancers

Authors: Gagandeep Brar, Dani Castillo, Thinzar Lwin, Mustafa Raoof, Pashtoon Kasi, Marwan Fakih, S. Peter Wu

Read the Full Article on Clinical Colorectal Cancer 

Gagan Brar: Systemic Chemotherapy Shows No Added Role With CRS/HIPEC in Appendiceal Cancers

More posts featuring Gagan Brar.